BioCatalystWatch
LTRNWorkspace / LTRN / OverviewCompany library
Price
Market cap
Next catalystExpected 2H 2026LP-300 — HARMONIC · Phase 2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

LP-300

Small molecule

PTPN11

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

LP-300

Small molecule

PTPN11

Upcoming / outlook

Small molecule

PreINDP1P3FilingApproved
Upcoming / outlook

LP-284

Small molecule

PKC-β

PreINDP1P2P3FilingApproved
Upcoming / outlook

STAR-001

Small molecule

Upcoming / outlook

ADC

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Small molecule

PreINDP1P3FilingApproved
Upcoming / outlook

LP-300

Small molecule

PTPN11

Upcoming / outlook

LP-300

Small molecule

PTPN11

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

LP-284

Small molecule

PKC-β

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

LP-184 (STAR-001)

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

STAR-001

Small molecule

PreINDP1P2P3FilingApproved
STAR-001

Small molecule

STAR-001

Small molecule

STAR-001

Small molecule

LP-A18

PreINDP1P2P3FilingApproved
LP-284

PKC-β

PreINDP1P2P3FilingApproved
LP-284

PKC-β

PreINDP1P2P3FilingApproved

Partner / License out

Small molecule

Estrogen receptor

PreINDP1P2P3FilingApproved

Small molecule

Protein disulfide isomerase (PDI)

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

History / paused

GSK-3β

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

LTRN PR & News

PR & News

LTRN SEC archive